Immediate Impact
24 standout
Citing Papers
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)
2024 Standout
Current therapy and drug resistance in metastatic castration-resistant prostate cancer
2023 Standout
Works of Ilias Goranitis being referenced
Australian Public Perspectives on Genomic Newborn Screening: Risks, Benefits, and Preferences for Implementation
2024
TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ilias Goranitis | 254 | 255 | 177 | 71 | 820 | |
| Vladimir Sergeevich Gordeev | 148 | 189 | 310 | 46 | 889 | |
| Георги Искров | 283 | 193 | 65 | 54 | 720 | |
| Alastair Kent | 168 | 293 | 109 | 39 | 766 | |
| Caroline Sanders | 85 | 119 | 109 | 66 | 980 | |
| Jeremy A. Labrecque | 56 | 186 | 64 | 50 | 849 | |
| Ridgely Fisk Green | 52 | 407 | 88 | 22 | 834 | |
| Amy Østertun Geirdal | 54 | 201 | 134 | 65 | 976 | |
| Hilary Burton | 60 | 448 | 50 | 38 | 776 | |
| Nathalie McIntosh | 74 | 110 | 144 | 41 | 860 | |
| Glenn K. Goodrich | 77 | 279 | 231 | 44 | 825 |
All Works
Login with ORCID to disown or claim papers
Loading papers...